BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 30892982)

  • 1. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
    Tsai YC; Schlaepfer T; Ignatova D; Chang YT; Valaperti A; Amarov B; Blanchard G; Pehr K; Vonow-Eisenring M; Urosevic-Maiwald M; Hoetzenecker W; Pascolo S; Iselin C; Fassnacht C; Dimitriou F; Bobrowicz M; Guenova E
    Br J Dermatol; 2023 Oct; 189(5):603-611. PubMed ID: 37409661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal Photopheresis-An Overview.
    Cho A; Jantschitsch C; Knobler R
    Front Med (Lausanne); 2018; 5():236. PubMed ID: 30211164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome.
    Breen ID; Brumfiel CM; Patel MH; Rosenthal AC; Rule WG; DiCaudo DJ; Craig FE; Pittelkow MR; Mangold AR
    JAAD Case Rep; 2021 Mar; 9():24-27. PubMed ID: 33604439
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome.
    Gao C; McCormack C; van der Weyden C; Goh MS; Campbell BA; Twigger R; Buelens O; Harrison SJ; Khoo C; Lade S; Prince HM
    Blood; 2019 Oct; 134(16):1346-1350. PubMed ID: 31467061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review.
    Berhan A; Damtie S; Almaw A; Legesse B; Sharew B; Getie B; Erkihun M; Solomon Y
    Immunotargets Ther; 2024; 13():235-246. PubMed ID: 38689598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.
    Esme P; Coban SN; Ugur B; Aylı M; Caliskan E
    Transfus Apher Sci; 2021 Oct; 60(5):103200. PubMed ID: 34215520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.
    Lagacé F; Netchiporouk E; Turchin I; Gulliver W; Dutz J; Kirchhof MG; Popradi P; Gniadecki R; Lynde C; Litvinov IV
    Skin Therapy Lett; 2022 Sep; 27(5):1-6. PubMed ID: 36469458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
    Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
    Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
    Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma.
    Seremet S; Abhyankar S; Herd TJ; Aires D
    J Drugs Dermatol; 2016 Oct; 15(10):1212-1216. PubMed ID: 27741338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
    Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
    Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
    Ling YL; Huang X; Mitri G; Lovelace B; Pham A; Knobler R; Li X; Gao X
    J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.